Fully Closed-Loop Insulin Delivery System Improves Glucose Control in T2DM
FRIDAY, Jan. 27, 2023 (HealthDay News) -- For adults with type 2 diabetes, a fully closed-loop insulin delivery system improves glucose control without increasing hypoglycemia compared with standard insulin therapy, according to a study published online Jan. 11 in Nature Medicine.
Aideen B. Daly, M.B.B.S., from the Wellcome-MRC Institute of Metabolic Science at Addenbrooke's Hospital in Cambridge, England, and colleagues conducted a randomized crossover study to compare eight weeks of the CamAPS HX fully closed-loop app with standard insulin therapy and a masked glucose sensor (control). A two- to four-week washout period separated the treatments. Twenty-eight participants were randomly assigned to two groups (14 each to closed-loop therapy first and control therapy first).
The researchers found that the proportion of time in the target glucose range (3.9 to 10.0 mmol l-1) was 66.3 ± 14.9 percent and 32.3 ± 24.7 percent with closed-loop therapy and control therapy, respectively. Time >10.0 mmol l-1 was 33.2 ± 14.8 and 67.0 ± 25.2 percent with closed-loop therapy and control therapy, respectively. Compared with the control period, mean glucose was lower during the closed-loop therapy period (9.2 ± 1.2 mmol l-1 versus 12.6 ± 3.0 mmol l‑1). In addition, hemoglobin A1c was lower following closed-loop versus control therapy (57 ± 9 mmol mol-1 versus 72 ± 13 mmol mol-1). The groups had a similar time <3.9 mmol l-1. Severe hypoglycemia events did not occur in either period.
"This study suggests that fully closed-loop insulin delivery is a safe and efficacious approach to manage type 2 diabetes in adults," the authors write.
Dexcom supplied discounted continuous glucose monitoring devices and sensors for the study.
Related Posts
Calcium Supplements, Mortality Tied in Seniors With Aortic Stenosis
TUESDAY, April 26, 2022 (HealthDay News) -- For older adults with aortic...
Lower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company Says
MONDAY, Sept. 20, 2021 (HealthDay News) -- A smaller dose of Pfizer's...
Un parche cutáneo podría ayudar a aliviar la alergia al cacahuate de los niños pequeños
JUEVES, 11 de mayo de 2023 (HealthDay News) -- Un "parche de cacahuate" que se...
Comprar marihuana en línea es fácil para menores, según un estudio
MIÉRCOLES, 27 de septiembre de 2023 (HealthDay News) – La laxa aplicación de los...